Purchase Order HHSN268201700284A

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order contract to Biofortis, LLC for Labmatrix license software. The potential value of the contract is $173,394.00 with a performance period through December 31, 2024. Biofortis is a clinical trial laboratory services organization that provides the Labmatrix software platform to support data management for cancer and genomics research programs...

<p>The National Human Genome Research Institute awarded a purchase order to Biodiscovery, Inc. for $16,031.25 on December 18, 2017. Work is performed in Bethesda, Maryland. The order is for firm fixed price, with no small business set-aside. Ultimate completion is scheduled for December 29, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Chesapeake Mission Critical LLC valued at $13,871.00 on August 25, 2017, with a completion date of September 8, 2017. Work is performed in Bethesda, Maryland. The order is priced on a firm-fixed-price basis with no set-aside applied. Specific requirements are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Biovisualization LLC for $19,999.20 on June 4, 2026 to modernize a web application supporting a telemedicine study. Work is performed in Bethesda, Maryland. The order is priced on a firm fixed price basis with an ultimate completion date of June 3, 2027.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Bio Basic Canada Inc. for $1,834.68 on February 26, 2016. Performance is located in Bethesda, Maryland. The order carries a firm fixed price and no set-aside designation. Ultimate completion was scheduled for December 29, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences Of California, Inc. on July 7, 2017, for $4,525.00 under firm fixed-price terms. Work is to be performed in North Bethesda, Maryland, with an ultimate completion date of August 6, 2017. The purchase order covers sequencing consumables or reagents supporting the institute's genomic research operations.</p>